Yongxin Mao

Ruijin Hospital, Shanghai Jiao Tong University

Papers

2

Total Citations

66

H-Index

2

About

Dr. Yongxin Mao is a leading surgeon-scientist advancing the field of minimally invasive adrenal surgery. His research focuses on comparing robotic and laparoscopic techniques for adrenalectomy, particularly for complex cases like pheochromocytoma. Dr. Mao’s most impactful work is his 2020 randomized controlled trial comparing robotic versus laparoscopic adrenalectomy for pheochromocytoma, which has garnered 51 citations and provides critical evidence on surgical outcomes for this challenging tumor type. He further demonstrated his expertise through a propensity score matched analysis of 401 patients comparing robotic-assisted with laparoscopic posterior retroperitoneal adrenalectomy (RPRA vs. LPRA), a study with 15 citations that helps identify which patients benefit most from the robotic approach. By systematically evaluating perioperative outcomes and patient selection criteria, Dr. Mao’s contributions are directly shaping clinical decision-making and improving surgical precision in adrenal tumor management. His work stands as a valuable resource for surgeons and researchers seeking to optimize minimally invasive techniques and enhance patient recovery.

Research Focus

Key Achievements

2
H-Index
2
Papers
66
Total Citations
33
Avg Citations/Paper
🏆 Most Cited Paper
Surgical outcomes of a randomized controlled trial compared robotic versus laparoscopic adrenalectomy for pheochromocytoma
51 citations · 2020
📈 Most Prolific Year: 2020 (2 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Ruijin Hospital, Shanghai Jiao Tong University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago